Berirab P 750IU Injection
By Berirab P
Rx
5ml Injection in a Prefilled syringe

Composition
Human Rabies Immunoglobulin(750IU)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
July, 2025

liver
Berirab P 750IU Injection may be considered safe for use in patients with liver disease. The available data indicates that it may not be necessary to adjust the dose of Berirab P 750IU Injection for these patients. It is important to consult with your doctor before using this injection, especially if you have any liver-related concerns.

kidney
Berirab P 750IU Injection is likely safe for patients with kidney disease. Data shows dose adjustment may not be required. Remember to seek advice from your doctor.

alcohol
Consult your doctor when consuming alcohol with Berirab P 750IU Injection.

driving
Berirab P 750IU Injection typically does not impact your driving ability.

pregnancy
Berirab P 750IU Injection is considered safe during pregnancy, based on animal studies indicating minimal adverse effects on the baby. Limited human studies are available.

breastfeeding
Berirab P 750IU Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Habit Forming | No |
Chemical Class | Vaccines |
Therapeutic Class | - |
Action Class | - |
₹5714.28
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025